Rolf-Stefan Brickl

Title: Rolf-Stefan Brickl: Innovator in Pharmaceutical Preparations

Introduction

Rolf-Stefan Brickl is a notable inventor based in Warthausen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of four patents to his name, Brickl's work focuses on improving the efficacy and delivery of medications.

Latest Patents

Among his latest patents is a solid ambroxol-containing preparation. This invention relates to solid preparations that are obtainable by melt extrusion of a mixture consisting of ambroxol hydrochloride and various excipients. The formulation is designed for secretolytic treatment in acute and chronic bronchopulmonary diseases. Another significant patent is for an extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof. This pellet comprises an active ingredient selected from pramipexole and includes at least one release-modifying excipient.

Career Highlights

Rolf-Stefan Brickl has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim International GmbH and Sanofi-Aventis Deutschland GmbH. His experience in these organizations has contributed to his expertise in drug formulation and development.

Collaborations

Throughout his career, Brickl has collaborated with several professionals, including Jürgen Schraivogel and Herrad-Odilia Krenkel. These collaborations have likely enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Rolf-Stefan Brickl is a distinguished inventor whose work in pharmaceutical preparations has the potential to improve treatment options for patients. His innovative patents reflect his commitment to advancing medical science and enhancing drug delivery systems.